(Bloomberg) -- China's food and drug regulator
strengthened penalties for making fake medicines and tightened
standards for approving new drugs, aiming to clean up an industry
saddled with corruption and fraud.
Companies that send in fake medicine samples for approvals
will be fined as much as 30,000 yuan ($3,967) and face a three-
year ban from drug tests, deputy head of the State Food and Drug
Administration's supervision department Wu Zhen said in a Webcast
today on the agency's Web site.
Read more at Bloomberg Emerging Markets News
strengthened penalties for making fake medicines and tightened
standards for approving new drugs, aiming to clean up an industry
saddled with corruption and fraud.
Companies that send in fake medicine samples for approvals
will be fined as much as 30,000 yuan ($3,967) and face a three-
year ban from drug tests, deputy head of the State Food and Drug
Administration's supervision department Wu Zhen said in a Webcast
today on the agency's Web site.
Read more at Bloomberg Emerging Markets News
No comments:
Post a Comment